Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Darzalex Faspro for newly diagnosed light-chain amyloidosis

Jan. 18, 2021

FDA approves Xalkori for ALK-positive ALCL in children and young adults

Jan. 15, 2021

Chinese approval of Rykindo for schizophrenia and psychotic states

Jan. 15, 2021

Tislelizumab approved in China for first-line advanced squamous NSCLC

Jan. 14, 2021

Saroglitazar magnesium approved in India for NAFLD

Dec. 31, 2020

Sulanda approved in China for non-pancreatic NETs

Dec. 31, 2020

U.K. MHRA authorizes AstraZeneca's COVID-19 vaccine for emergency supply

Dec. 30, 2020

Orelabrutinib approved in China for two cancer indications

Dec. 28, 2020

FDA approves Kineret to treat deficiency of IL-1 receptor antagonist

Dec. 23, 2020

FDA approves Ebanga for the treatment of Zaire ebolavirus

Dec. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...